期刊文献+

Expression of Rab25 correlates with the invasion and metastasis of gastric cancer 被引量:12

Expression of Rab25 correlates with the invasion and metastasis of gastric cancer
在线阅读 下载PDF
导出
摘要 The objective of this study was to determine the expression of the important vesicle trafficking- regulating factor Rab25 in human gastric cancer tissues, to analyze the correlation between Rab25 protein expression with gastric cancer occurrence and development, and to discuss the correlation of Rab25 protein expression with gastric cancer cell metastasis. The overall aim was to provide experimental evidence that can be used to design future biological treatments of human gastric cancer. Human gastric cancer tissue and the adjacent normal gastric tissue were surgically removed, and immunohistochemistry and Western blotting were used to detect Rab25 protein expression. The correlation between Rab25 protein expression with the development and pathological characteristics of gastric cancer was analyzed. Using RNAi, Rab25 expression was reduced in the gastric cancer cell line MGC80-3, and the changes in MGC80-3 cell invasiveness were then monitored. Immunohistochemistry showed that the Rab25 protein expression rates were 78.21% and 23.08% in gastric carcinoma and the adjacent normal gastric tissue, respectively. Immunohistochemistry and Western blot results showed that Rab25 protein expression in gastric cancer was significantly higher than in adjacent normal gastric tissues (t)〈0.01). Less differentiated gastric cancer cells had higher expression of Rab25 protein (P〈0.01). Gastric carcinomas from patients with a late pathological stage (Ⅲ-Ⅳ) had significantly higher Rab25 protein expression than early stage (Ⅰ-Ⅱ) patients (P〈0.01). Gastric carcinomas from patients with lymph node metastasis had significantly higher Rab25 protein expression than lymph node metastasis- free patients (P〈0.01). Gastric carcinomas from patients with distant metastases had significantly higher Rab25 protein expression than the distant metastasis-negative patients (P〈0.01). Rab25 protein expression in gastric cancer was not affected by the patients' sex, age, or tumor size (P〉0.05). MGCS0-3 cells transfected with Rab25 siRNA had significantly lower Rab25 protein expression (P〈0.01) and a significantly lower number of cells that passed through a Transwell chamber compared with non-transfected controls and the transfected control group (P〈0.01). Rab25 protein expression is associated with the development of gastric cancer, siRNA knockdown of Rab25 protein expression in MGC80-3 gastric cancer cells reduced MGC80-3 cell invasiveness and provided experimental evidence for potential future biological treatment strategies of human gastric cancer. The objective of this study was to determine the expression of the important vesicle trafficking- regulating factor Rab25 in human gastric cancer tissues, to analyze the correlation between Rab25 protein expression with gastric cancer occurrence and development, and to discuss the correlation of Rab25 protein expression with gastric cancer cell metastasis. The overall aim was to provide experimental evidence that can be used to design future biological treatments of human gastric cancer. Human gastric cancer tissue and the adjacent normal gastric tissue were surgically removed, and immunohistochemistry and Western blotting were used to detect Rab25 protein expression. The correlation between Rab25 protein expression with the development and pathological characteristics of gastric cancer was analyzed. Using RNAi, Rab25 expression was reduced in the gastric cancer cell line MGC80-3, and the changes in MGC80-3 cell invasiveness were then monitored. Immunohistochemistry showed that the Rab25 protein expression rates were 78.21% and 23.08% in gastric carcinoma and the adjacent normal gastric tissue, respectively. Immunohistochemistry and Western blot results showed that Rab25 protein expression in gastric cancer was significantly higher than in adjacent normal gastric tissues (t)〈0.01). Less differentiated gastric cancer cells had higher expression of Rab25 protein (P〈0.01). Gastric carcinomas from patients with a late pathological stage (Ⅲ-Ⅳ) had significantly higher Rab25 protein expression than early stage (Ⅰ-Ⅱ) patients (P〈0.01). Gastric carcinomas from patients with lymph node metastasis had significantly higher Rab25 protein expression than lymph node metastasis- free patients (P〈0.01). Gastric carcinomas from patients with distant metastases had significantly higher Rab25 protein expression than the distant metastasis-negative patients (P〈0.01). Rab25 protein expression in gastric cancer was not affected by the patients' sex, age, or tumor size (P〉0.05). MGCS0-3 cells transfected with Rab25 siRNA had significantly lower Rab25 protein expression (P〈0.01) and a significantly lower number of cells that passed through a Transwell chamber compared with non-transfected controls and the transfected control group (P〈0.01). Rab25 protein expression is associated with the development of gastric cancer, siRNA knockdown of Rab25 protein expression in MGC80-3 gastric cancer cells reduced MGC80-3 cell invasiveness and provided experimental evidence for potential future biological treatment strategies of human gastric cancer.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2013年第2期192-199,共8页 中国癌症研究(英文版)
关键词 Rab2 5 human gastric cancer IMMUNOHISTOCHEMISTRY Western blot siRNA INVASION Rab2 5 human gastric cancer immunohistochemistry Western blot siRNA invasion
作者简介 Corresponding to: Maoquan Li, MD, PhD. Department of Interventional Radiology, Shanghai 10^th People's Hospital, Tongji University, No. 301, Yanchang Rd, Shanghai 200072, China. Email: drmaoquan.li@gmail.com.
  • 相关文献

参考文献4

二级参考文献47

  • 1Siewert JR, Bottcher K, Stein H J, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228: 449-61.
  • 2Iwanicki-Caron I, Di Fiore F, Roque I, et al. Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer. J Clin Oncol 2008; 26: 3681-6.
  • 3Ishigami S, Sakamoto A, Uenosono Y, et al. Carcinoembryonic antigen messenger RNA expression in blood can predict relapse in gastric cancer. J Surg Res 2008; 248: 205-9.
  • 4Yamamoto M, Baba H, Toh Y, et al. Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients. J Cancer Res Clin Oncol 2007; 133: 471-6.
  • 5Kim H J, Lee KW, Kim YJ, et al. Chemotherapy- induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer. Acta Onco12009; 48: 385-90.
  • 6Takahashi Y, Takeuchi T, Sakamoto J, et al. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients:a prospective clinical study. Gastric Cancer 2003; 6: 142-5.
  • 7Kochi M, Fujii M, Kanamori N, et al. Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer. Gastric Cancer 2000; 3: 177-86.
  • 8Ubukata H, Katano M, Motohashi G, et al. Evaluation of CA72-4 as a tumor marker in patients with gastric cancer. Gan To Kagaku Ryoho 2003; 30: 1821-4.
  • 9Sheng SL, Wang Q, Huang G. Development of time-resolved immunofluorometric assays for CA 72-4 and application in sera of patients with gastric tumors. Clin Chim Acta 2007; 380: 106-11.
  • 10Goral V, Yesilbagdan H, Kaplan A, et al. Evaluation of CA 72-4 as a new tumor marker in patients with gastric cancer. Hepatogastroenterology 2007; 54: 1272-5.

共引文献75

同被引文献37

引证文献12

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部